Neurology

Americans with anxiety, depression, and PTSD would be willing to try ketamine, psilocybin, and MDMA if they worked better than traditional medications, a Harris Poll finds.

Screening of older adults for falls and cognitive impairment should be routine in primary care; a recent study highlights an intervention that could help.

Suicidal thoughts and behaviors among US adults arise due to several factors, including geography, socioeconomic status, and race and ethnicity, according to new CDC report.

Intranasal CGRP inhibitor zavegepant met coprimary regulatory endpoints in pivotal phase 3 trial in adults with migraine; FDA submission planned for Q1 2022.

Headspace, Calm, and 3 more apps for COVID-19 frontline health care workers who need antidotes to anxiety and stress everywhere they go.

Five migraine management essentials for PCPs and headache patients are summarized with the mnemonic SEEDS. 

Treatment with aspirin of patients with cardiovascular risk factors was consistently associated with a greater than 25% risk of incident HF, another strike against the OTC antithrombotic.

Patients taking either of the 2 anticoagulants showed no large differences on 4 cognitive test scores at 2 years, according to authors of the GIRAF trial.

Smoking was associated with earlier onset of cardiovascular disease, by 5.1 years for men and 3.8 years for women, the new study found.

AHA Scientific Sessions 2021. Statin-associated muscle symptoms complicate treatment initiation and adherence; a new mHealth tool shows promise in reducing treatment cessation.

In the first review of its kind, authors found encouraging evidence supporting the use of hypnosis for chronic neuropathic pain treatment. Find key results in our new slideshow.

AHA 2021: E-cigarette users were found to have a 15% higher risk of a cerebrovascular accident at a younger age than those who smoked combustible tobacco cigarettes.

When addressing mental health with patients with obesity, a thoughtful approach that balances psychological health and weight loss is critical, explains Dr Ethan Lazarus.

The impact on sexual function of chronic pain conditions has received little research inquiry and requires much more focused clinical attention.

The USPSTF shift to a more conservative recommendation on use of aspirin compared to its 2016 stance is based on new RCT data and net benefit modeling.

Iron deficiency can't be causally linked to CHD yet, but evidence is accumulating for the association, according to authors of a new European study.

The temporal connection of atrial fibrillation and risk of ischemic stroke provides support for short-duration oral anticoagulation, said study authors.

EASD 2021: Patients with metabolically healthy obesity are nearly 33% more likely to develop heart failure and atrial fibrillation than healthy persons of normal weight, suggests new analysis.

The daily oral CGRP inhibitor is the only agent in the class developed specifically for prevention vs acute treatment of episodic migraine.

Clinical decisions on LDL-C management currently rely on a measure at one time point, typically middle age. A new study suggests burden begins early and so should assessment.

What state has the lowest suicide rate? Which one has the highest share of adult depression? Find the answers and more insights from a nationwide analysis, here.

The DHE nasal spray delivered pain relief at 2 hours for 66% of patients; 93% of those remained pain-free at 24 hours and 86% at 2 days post-dose.

Substituting regular salt with low-sodium alternative was found to reduce the risk of stroke, major cardiovascular events, and death in a new study presented at ESC Congress 2021.

Oral CGRP inhibitor atogepant significantly reduced monthly headache days and improved daily function in adults with 4 to 14 headaches per month.

A new study suggests that walking even 3 or 4 hours a week may reduce long-term mortality from any cause in patients with a history of stroke.